Retiro De Equipo (Recall) de Device Recall VITROS 4600 Chemistry System Software

Según U.S. Food and Drug Administration, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en United States que fue producido por Ortho-Clinical Diagnostics.

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    61910
  • Clase de Riesgo del Evento
    Class 2
  • Número del evento
    Z-2067-2012
  • Fecha de inicio del evento
    2012-05-21
  • Fecha de publicación del evento
    2012-07-23
  • Estado del evento
    Terminated
  • País del evento
  • Fecha de finalización del evento
    2018-07-05
  • Fuente del evento
    USFDA
  • URL de la fuente del evento
  • Notas / Alertas
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notas adicionales en la data
    Analyzer, chemistry (photometric, discrete), for clinical use - Product Code JJE
  • Causa
    Software automatically switches the lot when a vancomycin (vanc) or valproic acid (valp) reagent is depleted or the operator manually changes the lot in use causing lack of verification of proper quality assessment.
  • Acción
    Ortho Clinical Diagnostics notified its foreign direct account consignees via email on May 21, 2012 and their direct account US consignees were sent an Urgent Distributor Safety Notice on May 22, 2012 via US Postal Service Priority Letter. The recall letter notified the consignees of the situation and that Ortho will replace their remaining inventory of non-expired GENs 14 or 15 for VITROS VALP Reagent only. Until then the consignees can continue using the VITROS VALP Reagent, GENs 14 or 15 until the replacement arrives. And to note that VITROS VANC Reagent, GENs 19 &20 are now expired. --- The letter also requested the consignees to complete and return the enclosed Confirmation of Receipt, no later than May 31, 2012. And to review the quality control beginning with the Calibration date of the VITROS VANC Reagent ( GEN 21 or above) or VITROS VALP (GEN & above) so that the QC results can be verified to be within acceptable ranges. --- For customers using VITROS VALP Reagent GEN 14 or 15, they were to respond as to the quantity of the non-expired GENs 14 and 15 remaining inventory; to load and use only one GEN of VITROS VALP Reagent at a time on the system until the replacement arrives. This notification letter should be posted by each VITROS System using the VITROS VALP Reagent or VITROS VANC Reagent or with the user documentation. And in addition, if these products were distributed then this information should be forwarded as well. For questions regarding this recall call 585-453-4110.

Device

  • Modelo / Serial
    Version 2.0 & Below
  • Clasificación del producto
  • Clase de dispositivo
    1
  • ¿Implante?
    No
  • Distribución
    Worldwide Distribution - USA (nationwide) and the countries of Australia, New Zealand, Brazil, Canada, Chile, Argentina, Paraquay, Ecuador, Colombia, India, Japan, Mexico, Panama, Singapore, Venezuela, UK, Northern Europe, France, Germany, Italy, Spain and Portugal.
  • Descripción del producto
    VITROS 4600 Chemistry System Software || For use in the in-vitro quantitative, semi quantitative, and qualitative measurement of variety of analytes of clinical interest.
  • Manufacturer

Manufacturer

  • Dirección del fabricante
    Ortho-Clinical Diagnostics, 100 Indigo Creek Dr, Rochester NY 14626-5101
  • Empresa matriz del fabricante (2017)
  • Source
    USFDA